Category Archives: Cell Therapy

Beverly Hills, California (PRWEB) May 28, 2014

The Beverly Hills Orthopedic Institute is now offering stem cell procedures for patients with shoulder injuries to help achieve pain relief and avoid surgery. For individuals with rotator cuff tears, shoulder dislocations and tendonitis, the injections may heal the condition and get patients back into desired activities. For more information and scheduling, call (310) 247-0466.

When a person sustains a shoulder injury traumatically such as a rotator cuff tear or a shoulder dislocation, chronic pain may result ending up in a need for surgery. Surgery is often successful, however, there are significant risks and a potential lengthy recovery period.

As a Double Board Certified Los Angeles orthopedic surgeon, Dr. Raj has been a pioneer in stem cell procedures for shoulder injuries along with degenerative arthritis. He said, "Regenerative medicine procedures for shoulder injuries have been revolutionary. If you look at what happened to a professional dancer like Mark Ballas recently on Dancing With the Stars where he dislocated his shoulder, stem cell therapy can help stabilize the joint."

The stem cell procedures are performed as an outpatient and involve one of two methods. The first involves bone marrow derived stem cells, which are harvested directly from the patient, immediately processed, and then injected into the shoulder. The therapy contains concentrated stem cells and growth factors.

The second therapy option involves amniotic derived stem cells, which contain no embryonic stem cells and therefore avoid any ethical concerns. The amniotic fluid is processed at an FDA regulated lab, causes no rejection issues and is rich with stem cells, growth factors and hyaluronic acid.

Said Dr. Raj, "The combination of stem cells, growth factors, hyaluronic acid and cytokines in the fluid has been amazing for healing shoulder injuries. We've been able to help a lot of patients avoid the need for surgery and get back to high level athletic activities much sooner than with a surgery and associated rehab!"

Beverly Hills Orthopedic Institute accepts most insurance plans. Dr. Raj is an ABC News Medical Correspondent and a WebMD medical expert. For more information about the stem cell therapy and to make appointments, call (310) 247-0466.

View original post here:
Beverly Hills Orthopedic Institute Now Offering Stem Cell Procedures for Shoulder Injuries to Help Patients Achieve ...

Block GmbH Centre for Living Cell Therapy
The fresh cell therapy/stem cell therapy is always a full body treatment. The improvement of the function of individual organs also affects all other organs ...

By: VIPiChannel

See the original post here:
Block GmbH Centre for Living Cell Therapy - Video

Whiplash headaches 11 months after stem cell therapy by Dr Harry Adelson
Neil discusses his outcome 11 months after his stem cell therapy by Dr Harry Adelson for the treatment of his post-whiplash headache syndrome http://www.docereclinics.com.

By: Harry Adelson, N.D.

Excerpt from:
Whiplash headaches 11 months after stem cell therapy by Dr Harry Adelson - Video

Poway, California (PRWEB) May 22, 2014

Zeke was in pain from arthritis caused by an old injury and was facing possible surgery on both knees. Christine Ponsness-Wetzel, DVM, at Pend Oreille Veterinary Service determined that Zeke was a good candidate for stem cell therapy by Vet-Stem, Inc. as an alternative, and just a few months later, he now has a bounce back in his step.

Zeke is a 125-pound Leonberger who lives in Idaho and enjoys going on back country ski trips. Zekes hobbies came to a halt two years ago when he was diagnosed with a partial cruciate ligament tear. He had gone lame and two weeks of rest was recommended, but his owners did not see improvement. After a month of rest, x-rays revealed arthritis had developed in one of Zekes knees.

After a year of pain medications to control the discomfort and pain, Zeke started having more difficulties. He had a delayed ability to comfortably bend his leg, often needed help getting up from a laying position, and would whimper in pain. This time, x-rays would reveal arthritis in both knees. After a few months of increased pain medications and only mild improvement, Zekes owners opted for stem cell therapy with Dr. Ponsness-Wetzel.

Zeke was still quite active and happy, so the thought of double knee surgery and the long recovery time was not in my books, so we opted for stem cell therapy, Zekes owner explains. It has been four months since the stem cell injections (both knees and an IV dose) and Zeke has definitely improved. He no longer needs help getting up. He does not whimper in pain. His delay in bending his knee is non-existent, and his pain medication has been reduced by about 80%. Hikes are no longer sheer drudgery and he has a bounce in his step that I forgot existed.

Pend Oreille Veterinary Services celebrates its 50th anniversary in the Bonner County, providing basic health care services to small animals and reptiles, as well as cutting edge therapies such as acupuncture, laser, and stem cells. Pend Oreille Veterinary Services also offers boarding and grooming to the cities around their two locations in Ponderay and Bonners Ferry. To find out more about Pend Oreille Veterinary Service and Vet-Stem Cell Therapy with Dr. Ponsness-Wetzel, visit http://www.sandpointvets.com.

About Vet-Stem, Inc. Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.

More:
Stem Cell Therapy Provided by Pend Oreille Veterinary Service Helps Local Leonberger Get the Bounce Back in His Step ...

Freeport, The Bahamas (PRWEB) May 20, 2014

Okyanos Heart Institute has announced the addition of Dr. Todd Malan to their executive medical team as Chief Cell Therapy Officer and General Surgeon. He will perform and oversee the liposuction step of Okyanos treatment, removing a small amount of fat from patients from which their own stem cells are isolated. Cardiac cell therapy is intended for no-option heart patients who have exhausted the currently available standards of care for their condition, of which there are about 2 million in the United States alone.

Dr. Malan is founder of the Innovative Cosmetic Surgery Center in Scottsdale, Arizona, specializing in advanced liposuction and fat transfer procedures. A pioneer in adipose- (fat) derived stem cell research and fellow of the American Academy of Cosmetic Surgery, Dr. Malan became the first physician in the United States to utilize adult stem cells from fat tissue for soft tissue reconstruction. He has co-authored two medical textbooks on fat-derived stem cell therapies and has served as principal investigator on two Institutional Review Board- (IRB) approved adult stem cell trials.

As an active member of the adipose stem cell research community, Dr. Malan is very familiar with the therapeutic benefits of adult stem cells for cardiac, as demonstrated in clinical trials, said Dr. Howard Walpole, chief medical officer at Okyanos. He lends his experience and integrated knowledge of both innovative cosmetic surgery and stem cell therapy to our medical leadership team, he added.

"It is truly gratifying to see the gathering of like-minded researchers, clinicians, and administrators who see the remarkable value of developing evidence-based protocols for effective stem cell therapies, said Dr. Malan. He added, This project is a culmination of years of experience between industry leaders who are dedicated to making Okyanos a premier cell therapy center in the world. The work we do today will define the future of medicine for years to come."

Okyanos cardiac cell therapy is the first stem cell-based procedure for heart failure available to patients outside of clinical trials, wherein the patients own adipose-derived stem cells are infused directly into the damaged part of the heart via catheter. Okyanos will begin treating advanced heart disease patients in Freeport, The Bahamas, in the summer of 2014.

ABOUT OKYANOS HEART INSTITUTE: [Oh key AH nos] Based in Freeport, The Bahamas, Okyanos Heart Institutes mission is to bring a new standard of care and a better quality of life to patients with coronary artery disease using cardiac stem cell therapy. Okyanos adheres to U.S. surgical center standards and is led by founder and CEO Matt Feshbach, as well as Chief Medical Officer Howard T. Walpole Jr., M.D., M.B.A., F.A.C.C., F.S.C.A.I. Okyanos Treatment utilizes a unique blend of stem and regenerative cells derived from ones own adipose (fat) tissue. The cells, when placed into the heart via a minimally-invasive procedure, can stimulate the growth of new blood vessels, a process known as angiogenesis. Angiogenesis facilitates blood flow in the heart, which supports intake and use of oxygen (as demonstrated in rigorous clinical trials such as the PRECISE trial). The literary name Okyanos, the Greek god of rivers, symbolizes restoration of blood flow.

For more information, please visit http://www.okyanos.com/.

Read this article:
Dr. Todd Malan Named Chief Cell Therapy Officer at Okyanos Heart Institute

Stem Cell Therapy using Bone Marrow Derived Mononuclear Cells in Treatment of Lower Limb Lymphedema

By: osama ashmawy

Original post:
Stem Cell Therapy using Bone Marrow Derived Mononuclear Cells in Treatment of Lower Limb Lymphedema - Video

In this image, the top row shows the stem cells transplanted into the mouse spinal cord. The lower row shows a close-up of the stem cells (brown). By day 7 post-transplant, the stem cells are no longer detectable. Within this short period of time, the stem cells have sent chemical signals to the mouses own cells, enabling them to repair the nerve damage caused by MS. (image: Lu Chen)

For patients with multiple sclerosis (MS), current treatment options only address early-stage symptoms of the debilitating disease. Now, new research has found a potential treatment that could both stop disease progression and repair existing damage.

In a study published in Stem Cell Reports, researchers utilized a group of paralyzed mice genetically engineered to have an MS-like condition. Initially, the researchers set out to study the mechanisms of stem cell rejection in the mice. However, two weeks after injecting the mice with human neural stem cells, the researchers made the unexpected discovery that the mice had regained their ability to walk.

This had a lot of luck to do with it; right place, right time co-senior author Jeanne Loring, director of the Center for Regenerative Medicine at The Scripps Research Institute in La Jolla, California, told FoxNews.com. [co-senior author Tom Lane] called me up and said, Youre not going to believe this. He sent me a video, and it showed the mice running around the cages. I said, Are you sure these are the same mice?

Loring, whose lab specializes in turning human stem cells into neural precursor cells, or pluripotent cells, collaborated with Tom Lane, a professor of pathology at the University of Utah whose focus is on neuroinflammatory diseases of the central nervous system. The team was interested in stem cell rejection in MS models in order to understand the underlying molecular and cellular mechanisms contributing to rejection of potential stem cell therapies for the disease.

Multiple sclerosis is an autoimmune disease that affects more than 2.3 million people worldwide. For people with MS, the immune system misguidedly attacks the bodys myelin, the insulating coating on nerve fibers.

In a nutshell, its the rubber sheath that protects the electrical wire; the axon that extends from the nerves cell body is insulated by myelin, Lane, who began the study while at the University of California, Irvine, told FoxNews.com

Once the myelin has been lost, nerve fibers are unable to transmit electric signals efficiently, leading to symptoms such as vision and motor skill problems, fatigue, slurred speech, memory difficulties and depression.

The researchers inadvertent treatment appeared to work in two ways. First, there was a decrease of inflammation within the central nervous system of the mice, preventing the disease from progressing. Secondly, the injected cells released proteins that signaled cells to regenerate myelin and repair existing damage.

While the stem cells were rejected in the mice after 10 days, researchers were able to see improvements for up to six months after initial implantation.

See the original post:
Stem cell therapy shows promise for multiple sclerosis

Contact Information

Available for logged-in reporters only

Newswise LA JOLLA, CAMay 15, 2014Mice crippled by an autoimmune disease similar to multiple sclerosis (MS) regained the ability to walk and run after a team of researchers led by scientists at The Scripps Research Institute (TSRI), University of Utah and University of California (UC), Irvine implanted human stem cells into their injured spinal cords.

Remarkably, the mice recovered even after their bodies rejected the human stem cells. When we implanted the human cells into mice that were paralyzed, they got up and started walking a couple of weeks later, and they completely recovered over the next several months, said study co-leader Jeanne Loring, a professor of developmental neurobiology at TSRI.

Thomas Lane, an immunologist at the University of Utah who co-led the study with Loring, said he had never seen anything like it. Weve been studying mouse stem cells for a long time, but we never saw the clinical improvement that occurred with the human cells that Dr. Loring's lab provided, said Lane, who began the study at UC Irvine.

The mices dramatic recovery, which is reported online ahead of print by the journal Stem Cell Reports, could lead to new ways to treat multiple sclerosis in humans.

"This is a great step forward in the development of new therapies for stopping disease progression and promoting repair for MS patients, said co-author Craig Walsh, a UC Irvine immunologist.

Stem Cell Therapy for MS

MS is an autoimmune disease of the brain and spinal cord that affects more than a half-million people in North America and Europe, and more than two million worldwide. In MS, immune cells known as T cells invade the upper spinal cord and brain, causing inflammation and ultimately the loss of an insulating coating on nerve fibers called myelin. Affected nerve fibers lose their ability to transmit electrical signals efficiently, and this can eventually lead to symptoms such as limb weakness, numbness and tingling, fatigue, vision problems, slurred speech, memory difficulties and depression.

Current therapies, such as interferon beta, aim to suppress the immune attack that strips the myelin from nerve fibers. But they are only partially effective and often have significant adverse side effects. Lorings group at TSRI has been searching for another way to treat MS using human pluripotent stem cells, which are cells that have the potential to transform into any of the cell types in the body.

More:
Stem Cell Therapy Shows Promise for MS in Mouse Model